AVIGI Therapeutics is a pre seed startup based in United States. 1 investor tracked.
AVIGI Therapeutics is a company headquartered in the United States. Its most recent tracked round is Pre-Seed. Brouky records 1 investor associated with the company.
AVIGI Therapeutics develops small molecule therapies targeting biological processes in serious diseases, with a focus on oncology and kidney disease. The company aims to halt cancer metastasis and protect kidney function through novel therapeutic approaches.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.